DJIA 16,424.85 162.29 1.00%
NASDAQ 4,086.23 0.00 0.00%
S&P 500 1,862.31 19.33 1.05%
market minute promo

AbbVie Inc.

NYSE: ABBV

48.12 0.26 (0.54%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ABBV $48.12 0.54%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.58
Previous Close $47.86
Daily Range $47.62 - $48.84
52-Week Range $40.10 - $54.78
Market Cap $76.4B
P/E Ratio 18.70
Dividend (Yield) $1.68 (3.5%)
Ex-Dividend Date
Dividend Pay Date
04/11/14
05/15/14
Volume 7,150,999
Average Daily Volume 6,607,001
Current FY EPS $3.12

Sector

Industry

AbbVie Inc. (ABBV) Description

AbbVie Inc. Website: http://www.abbvie.com/

News & Commentary Rss Feed

Does the Latest HCV Breakthrough Therapy Spell Trouble for Gilead Sciences, Inc.?

See what three competing HCV combos with breakthrough designations will do to Gilead's blockbuster.

Glaxo's Tanzeum Approved in the U.S. - Analyst Blog

Abbott Labs Tops Earnings, Misses Sales Est - Analyst Blog

Abbott Labs Tops Earnings, Misses Sales Est - Analyst Blog

ITOT, QCOM, MCD, ABBV: Large Outflows Detected at ETF

Bristol-Myers Seeks Approval for HIV Combo Drug - Analyst Blog

Repros Completes Enrollment for Androxal Study - Analyst Blog

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog

Positive Data on AbbVie's HCV Program - Analyst Blog

Positive Data on AbbVie's HCV Program - Analyst Blog

Benzinga's Top #PreMarket Losers

Abbott Labs Progresses with Absorb - Analyst Blog

Abbott Labs Progresses with Absorb - Analyst Blog

Encouraging Data from Bristol-Myers - Analyst Blog

See More ABBV News...